Iterum Therapeutics plc (ITRMF) Total Debt (2018 - 2024)

Iterum Therapeutics' Total Debt history runs 7 years deep, the most recent figure standing at $14.5 million for Q4 2024.

• In Q4 2024, Total Debt rose 26.28% year-over-year to $14.5 million; the TTM figure through Dec 2024 stood at $14.5 million (up 26.28% YoY), while the FY2024 annual figure was $14.5 million, up 26.28% from the prior year.
• Total Debt for Q4 2024 stood at $14.5 million, up from $13.7 million in the prior quarter.
• The five-year high for Total Debt was $28.8 million in Q4 2020, with the low at $7.7 million in Q1 2022.
• The 5-year median for Total Debt is $11.9 million (2023), against an average of $14.2 million.
• The sharpest annual moves came in 2020 and 2021: Total Debt soared 114.79% in 2020, then sank 70.33% in 2021.
• Iterum Therapeutics' Total Debt stood at $28.8 million in 2020, then tumbled by 70.33% to $8.6 million in 2021, then advanced by 17.96% to $10.1 million in 2022, then advanced by 13.46% to $11.5 million in 2023, then advanced by 26.28% to $14.5 million in 2024.
• Business Quant data shows ITRMF's Total Debt at $14.5 million in Q4 2024, $13.7 million in Q3 2024, and $13.0 million in Q2 2024.